Annals of Surgical Oncology

, Volume 14, Issue 8, pp 2221–2227 | Cite as

Size of Sentinel Node Tumor Deposits and Extent of Axillary Lymph Node Involvement: Which Breast Cancer Patients May Benefit From Less Aggressive Axillary Dissections?

  • Elena Samoilova
  • Joseph T. Davis
  • Jeffrey Hinson
  • Yolanda M. Brill
  • Michael L. Cibull
  • Patrick McGrath
  • Edward Romond
  • Angela Moore
  • Luis M. Samayoa
Breast Oncology



In most breast cancer series, nearly 30% to 40% of all patients are sentinel node positive; however, in a large proportion of these, the disease is limited to three or fewer positive nodes. On the basis of these observations, the object of this study is to identify a subset of patients who might benefit from a less aggressive axillary dissection, without compromising staging or local disease control.

We reviewed known clinicopathologic variables associated with a higher risk for axillary metastasis in 467 patients who underwent sentinel node mapping at our institution. We then compared the incidence of these variables in patients with N1a versus N2–3 stage disease.


Although the presence of lymphvascular invasion in the primary tumor and extracapsular extension of tumor in the sentinel node were statistically significantly different between N1a and N2–3 patients (P < .025 and P < .01, respectively), the variable that most reliably separated N1a from N2–3 patients was the size of the tumor deposits in the sentinel node (P < .001). All patients with sentinel node tumor deposits ≤5 mm had three or fewer positive nodes; 95% were sentinel node–positive only, and 91% had single-node involvement.


Patients at low risk for extensive axillary nonsentinel node involvement may benefit from a more conservative surgical approach to their axillae, perhaps limited to sentinel node biopsy only or to axillary procedures restricted to the group of axillary nodes in close proximity to those designated as sentinel nodes.


Sentinel node Conservative axillary dissection Minimal axillary disease Size of tumor deposits. 


  1. 1.
    Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391–8PubMedCrossRefGoogle Scholar
  2. 2.
    Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer—a multicenter validation study. N Engl J Med 1998;339:941–6PubMedCrossRefGoogle Scholar
  3. 3.
    Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 1999;6:756–61PubMedCrossRefGoogle Scholar
  4. 4.
    Sachdev U, Murphy K, Derzie A, et al. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Am J Surg 2003;183:213–7CrossRefGoogle Scholar
  5. 5.
    Reynolds C, Mick R, Donohue JH, et al. Sentinel node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer. J Clin Oncol 1999;17:1720–6PubMedGoogle Scholar
  6. 6.
    Turner RR, Chu KU, Qi K, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574–81PubMedCrossRefGoogle Scholar
  7. 7.
    Kamath VJ, Giuliano R, Dauway EL, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001;136:688–92PubMedCrossRefGoogle Scholar
  8. 8.
    Rutledge H, Davis J, Chiu R, et al. Sentinel node micrometastasis in breast carcinoma may not be an indication for complete axillary dissection. Mod Pathol 2005;18:762–8PubMedCrossRefGoogle Scholar
  9. 9.
    Samayoa LM, Witzke D, Sloan D, et al. Defining sentinel lymph nodes in breast carcinoma. Mod Pathol 2001;14:189Google Scholar
  10. 10.
    Degnim A, Reynolds C, Pantvaidya G, et al. Non-sentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am J Surg 2005;190:543–50PubMedCrossRefGoogle Scholar
  11. 11.
    Schulze T, Mucke J, Markwardt J, et al. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 2006;93:109–19PubMedCrossRefGoogle Scholar
  12. 12.
    Burak WE, Hollenbeck ST, Zervos EE, et al. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Curr Surg 2004;61:259–63CrossRefGoogle Scholar
  13. 13.
    Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer Suppl 1998;83:2776–81Google Scholar
  14. 14.
    Geller BM, Vacek PM, O’Brien P, Secker-Walker RH. Factors associated with arm swelling after breast cancer surgery. J Womens Health 2003;12:921–30CrossRefGoogle Scholar
  15. 15.
    Voogd AC, Ververs JM, Vingerhoets AJ, Roumen RM, Coebergh JW, Crommelin MA. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg 2003;90:76–81PubMedCrossRefGoogle Scholar
  16. 16.
    Morrell RM, Halyard MY, Schild SE, Ali MS, Gunderson LL, Pockaj BA. Breast cancer–related lymphedema. Mayo Clin Proc 2005;80:1480–4PubMedCrossRefGoogle Scholar
  17. 17.
    Armer JM. The problem of post–breast cancer lymphedema: impact and measurement issues. Cancer Invest 2005;23:76–83PubMedCrossRefGoogle Scholar
  18. 18.
    Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 2003;80:233CrossRefGoogle Scholar
  19. 19.
    Carcoforo P, Maestroni U, Querzoli P, et al. Primary breast cancer features can predict additional lymph node involvement in patients with sentinel node micrometastases. World J Surg 2006;30:1653–7PubMedCrossRefGoogle Scholar
  20. 20.
    Maffuz A, Barroso-Bravo S, Najera I, Zarco G, Alvarado-Cabrero I, Rodriguez-Cuevas SA. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ. J Exp Clin Cancer Res 2006;25:223–7PubMedGoogle Scholar
  21. 21.
    Ozmen V, Karanlik H, Cabioglu N, et al. Factors predicting the sentinel and non- sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat 2006;95:1–6PubMedCrossRefGoogle Scholar
  22. 22.
    Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. Eur J Surg Oncol 2006;32:29–33PubMedCrossRefGoogle Scholar
  23. 23.
    Yu JC, Hsu GC, Hsieh CB, Sheu LF, Chao TY. Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J Surg 2005;7:813–8CrossRefGoogle Scholar
  24. 24.
    Cao Y, Paner GP, Rajan PB. Sentinel node status and tumor characteristics: a study of 234 invasive breast carcinomas. Arch Pathol Lab Med 2005;129:82–4PubMedGoogle Scholar
  25. 25.
    Viale G, Zurrida S, Maiorano E, et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 2005;103:492–500PubMedCrossRefGoogle Scholar
  26. 26.
    Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE, ALMANAC Trialists Group. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 2004;40:1731–7PubMedCrossRefGoogle Scholar
  27. 27.
    Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis. Arch Surg 2004;139:648–51PubMedCrossRefGoogle Scholar
  28. 28.
    Saidi RF, Dudrick PS, Remine SG, Mittal VK. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer. Am Surg 2004;70:101–5PubMedGoogle Scholar
  29. 29.
    van Iterson V, Leidenius M, Krogerus L, von Smitten K. Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res Treat 2003;82:39–45PubMedCrossRefGoogle Scholar
  30. 30.
    Degnim AC, Griffith KA, Sabel MS, et al. Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer 2003;98:2307–15PubMedCrossRefGoogle Scholar
  31. 31.
    Hwang RF, Krishnamurthy S, Hunt KK, et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003;10:248–54PubMedCrossRefGoogle Scholar
  32. 32.
    Chen M, Palleschi S, Khoynezhad A, Gecelter G, Marini CP, Simms HH. Role of primary breast cancer characteristics in predicting positive sentinel lymph node biopsy results: a multivariate analysis. Arch Surg 2002;137:606–9PubMedCrossRefGoogle Scholar
  33. 33.
    Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001;25:767–72PubMedCrossRefGoogle Scholar
  34. 34.
    Beenken SW, Urist MM, Zhang Y, et al. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg 2003:237:732–8PubMedCrossRefGoogle Scholar
  35. 35.
    Travagli JP, Atallah D, Mathieu MC, et al. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur J Surg Oncol 2003;29:403–6PubMedCrossRefGoogle Scholar
  36. 36.
    Lee AH, Pinder SE, Macmillan RD, et al. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. Eur J Cancer 2006;42:357–62PubMedCrossRefGoogle Scholar
  37. 37.
    Tan YY, Wu CT, Fan YG, et al. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J 2005;11:338–43PubMedCrossRefGoogle Scholar
  38. 38.
    Callejo IP, Brito JA, Bivar JW, et al. Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node. Clin Transl Oncol 2005;7:18–22PubMedGoogle Scholar
  39. 39.
    Viale G, Maiorano E, Pruneri G, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005;241:319–25PubMedCrossRefGoogle Scholar
  40. 40.
    Katz A, Niemierko A, Gage I, et al. Can axillary dissection be avoided in patients with sentinel lymph node metastasis? J Surg Oncol 2006;93:550PubMedCrossRefGoogle Scholar
  41. 41.
    Zavagno G, De Salvo GL, Bozza F, et al. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer. Breast Cancer Res Treat 2004;86:171–9PubMedCrossRefGoogle Scholar
  42. 42.
    Abdessalam SF, Zervos EE, Prasad M, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001;182:316–20PubMedCrossRefGoogle Scholar
  43. 43.
    Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchik A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536–41PubMedCrossRefGoogle Scholar
  44. 44.
    Weiser MR, Montgomery LL, Tan LK, et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001;8:145–9PubMedCrossRefGoogle Scholar
  45. 45.
    Chagpar AB, Scoggins CR, Martin RC, et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am J Surg 2006;192:882–7PubMedCrossRefGoogle Scholar
  46. 46.
    Chagpar AB, Scoggins CR, Martin RC, et al. Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 2007;14:670–7PubMedCrossRefGoogle Scholar
  47. 47.
    Bevilacqua JL, Cody HS III, MacDonald KA, Tan LK, Borgen PI, Van Zee KJ. A model for predicting axillary node metastases based on 2000 sentinel node procedures and tumour position. EJSO 2002;28:490–500PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2007

Authors and Affiliations

  • Elena Samoilova
    • 1
  • Joseph T. Davis
    • 1
  • Jeffrey Hinson
    • 1
  • Yolanda M. Brill
    • 1
  • Michael L. Cibull
    • 1
  • Patrick McGrath
    • 2
  • Edward Romond
    • 3
  • Angela Moore
    • 4
  • Luis M. Samayoa
    • 1
    • 5
  1. 1.Department of PathologyUniversity of Kentucky Breast Cancer CenterLexingtonUSA
  2. 2.Department of SurgeryUniversity of Kentucky Breast Cancer CenterLexingtonUSA
  3. 3.Department of Hematology and OncologyUniversity of Kentucky Breast Cancer CenterLexingtonUSA
  4. 4.Department of RadiologyUniversity of Kentucky Breast Cancer CenterLexingtonUSA
  5. 5.Department of PathologyVeterans Administration Medical CenterLexingtonUSA

Personalised recommendations